Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

F&S Sundhed & Behandling ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   10.3% 8.3% 6.0% 17.2% 22.5% 21.1% 15.9% 15.9%   Credit score (0-100)   25 31 39 8 3 4 12 12   Credit rating   BB BB BBB BB B B BB BB   Credit limit (kDKK)   0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   73.5 54.8 61.2 -328 4.1 -58.4 0.0 0.0   EBITDA   71.8 54.8 61.2 -328 4.1 -58.4 0.0 0.0   EBIT   68.2 51.2 57.6 -330 4.1 -58.4 0.0 0.0   Pre-tax profit (PTP)   152.1 48.7 48.8 -344.1 -195.4 1.5 0.0 0.0   Net earnings   139.6 37.9 38.0 -343.6 -195.4 1.5 0.0 0.0   Pre-tax profit without non-rec. items   152 48.7 48.8 -344 -195 1.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   9.8 6.2 2.6 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   60.0 97.9 136 -208 -403 -402 -452 -452   Interest-bearing liabilities   54.4 26.5 129 428 218 223 452 452   Balance sheet total (assets)   193 226 462 384 57.6 1.1 0.0 0.0   Net Debt   52.6 -1.9 129 428 218 223 452 452     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   73.5 54.8 61.2 -328 4.1 -58.4 0.0 0.0   Gross profit growth   -75.1% -25.4% 11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   193 226 462 384 58 1 0 0   Balance sheet change%   -32.0% 17.5% 104.0% -16.8% -85.0% -98.2% -100.0% 0.0%   Added value   71.8 54.8 61.2 -327.9 6.7 -58.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -7 -7 -7 -5 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   92.7% 93.4% 94.1% 100.8% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   58.4% 24.5% 16.7% -62.7% 36.6% -33.2% 0.0% 0.0%   ROI %   142.9% 42.9% 29.5% -95.2% -57.0% 12.1% 0.0% 0.0%   ROE %   81.3% 47.9% 32.5% -132.1% -88.4% 5.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   31.2% 43.3% 29.4% -35.1% -87.5% -99.7% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   73.2% -3.4% 210.7% -130.7% 5,289.6% -380.9% 0.0% 0.0%   Gearing %   90.6% 27.1% 94.9% -206.3% -54.0% -55.4% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   12.0% 6.3% 11.3% 4.9% 3.5% 11.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 1.7 1.4 0.6 0.1 0.0 0.0 0.0   Current Ratio   1.4 1.7 1.4 0.6 0.1 0.0 0.0 0.0   Cash and cash equivalent   1.9 28.4 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   50.2 91.7 133.9 -207.6 -403.0 -401.5 -225.8 -225.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 -58 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -58 0 0   EBIT / employee   0 0 0 0 0 -58 0 0   Net earnings / employee   0 0 0 0 0 1 0 0